Parents and clinicians are urged to review usage of certain health products for young children after federal authorities ...
Co., Ltd. (hereinafter referred to as "Sanyou Bio") and Shanghai ZJ Bio-Tech technology Co., Ltd. (hereinafter referred to as "Shanghai ZJ Bio-Tech") jointly announced the official signing of a ...
Researchers from IIT Madras and Ohio State University have developed an AI framework called PURE that can quickly generate drug-like molecules suitable for real-world synthesis. This innovation aims ...
The healthtech industry is on track to triple from $352 in 2025 to over $1.1T by 2032, driven by critical needs in provider capacity, aging populations, and chronic disease management.
Opinion
10hon MSNOpinion
DR. MAKARY, DR OZ: People talk about lowering health care costs, but the Trump administration is doing it
FDA announces major reforms to streamline biosimilar approvals, potentially saving Americans billions on prescription drug costs by removing extra clinical trial requirements.
Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") announced that clinical data on rusfertide in polycythemia vera, including the Phase 3 VERIFY study, will be the focus of four ...
IIT Madras announces the 'PURE' AI framework, promising significant reductions in drug development timelines. Developed with Ohio State University, PURE uses reinforcement learning to optimize ...
Trump administration officials have said that the deployment is not imminent but early stages of training for the potential ...
Prelude Therapeutics Incorporated continues to explore the SMARCA2 anticancer approach. Click here to read why PRLD stock is ...
November 3, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, announced ...
Dangerous drugs with an estimated value of ₱350 million were destroyed by authorities in Puerto Princesa City, Palawan, with the Philippine Drug Enforcement Agency (PDEA) saying that this was the ...
A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results